Three cases of immune cholangitis related to anti–programmed cell death and programmed cell death ligand agents for the treatment of non-small cell lung cancer-Reference-Cited by-同舟云学术

Three cases of immune cholangitis related to anti–programmed cell death and programmed cell death ligand agents for the treatment of non-small cell lung cancer

Published:2019-07 Issue: Volume:115 Page:107-110
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Fouchard Maxime,Jantzem Helene,Quere Gilles,Descourt Renaud,Robinet Gilles,Poureau Pierre-Guillaume

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference5 articles.

1. Nivolumab-induced cholangitic liver disease: a novel form of serious liver injury;Gelsomino;Ann Oncol 1 mars,2017

2. Bile duct obstruction in a patient treated with nivolumab as second-line chemotherapy for advanced non-small-cell lung cancer: a case report;Kashima;Cancer Immunol Immunother 1 janv,2018

3. A case of nivolumab-related cholangitis and literature review: how to look for the right tools for a correct diagnosis of this rare immune-related adverse event;Gelsomino;Invest New Drugs 1 févr,2018

4. EASL clinical practice guidelines: management of cholestatic liver diseases;European Association for the Study of the Liver;J Hepatol août,2009

5. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American society of clinical oncology clinical practice guideline;Brahmer;J Clin Oncol 10 juin,2018

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatobiliary complications of immune checkpoint inhibitors in cancer;Exploration of Targeted Anti-tumor Therapy;2024-07-26

2. Immune Checkpoint Inhibitor-induced Sclerosing Cholangitis: Three Cases Reported from Our Hospital;Haigan;2024-06-20

4. Drug-induced liver injury: An overview and update;Gastroenterology & Endoscopy;2023-04

5. Checkpoint inhibitor hepatotoxicity: pathogenesis and management;Hepatology;2023-01-13